Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Wushi Pharmaceutical Research Institute is the dedicated research and development arm of Hubei Wushi Pharmaceutical Co., Ltd., a major pharmaceutical manufacturer in China. The institute focuses on the modernization of Traditional Chinese Medicine (TCM) and the development of high-quality chemical generic drugs. Its core competencies include pharmaceutical formulation, quality standard enhancement, and the consistency evaluation of generic medications. The institute's research supports a diverse portfolio of products targeting respiratory, digestive, and cardiovascular health. By integrating traditional herbal knowledge with modern pharmacological standards, the institute plays a vital role in the parent company's growth and regulatory compliance strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 湖北午时医药研究院.